ITGAM and cancer: Observations in various cancer entities have found that the infiltration of CD11b+ myeloid cells supports tumor progression and is thus correlated with tumor size, lymph node metastasis, and poor prognosis, which has largely been attributed to the immunosuppressive function of TAM and MDSC [228].